5 papers to read suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah:
1.’Pancreatic Cancer Surveillance and Survival of High-Risk Individuals’ published in JAMA Oncology/Source/
Authors:
2.Comprehensive Discussions on KIT ATP-Binding Pocket/Activation Loop Mutations in Ripretinib Resistance published in Journal of Clinical Oncology/Source/
Authors: Yanzhe Xia and Xinhua Zhang
3. A study published in Nature outlines a clear pathway for how the Lupus disease likely develops, pointing to abnormalities in the immune systems of people with lupus. Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus/Source/ ‘Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus‘
Authors: Calvin Law, Vanessa Sue Wacleche, Ye Cao, Arundhati Pillai, John Sowerby, Brandon Hancock, Alice Horisberger, Sabrina Bracero, Viktoriya Skidanova, Zhihan Li, Ifeoluwakiisi Adejoorin, Eilish Dillon, Isaac J. Benque, Diana Pena Nunez, Daimon P. Simmons, Joshua Keegan, Lin Chen, Tina Baker, Phillip Z. Brohawn, Hussein Al-Mossawi, Ling-Yang Hao, Brian Jones, Navin Rao, Yujie Qu, Stephen E. Alves, Accelerating Medicines Partnership: RA/SLE Network, A. Helena Jonsson, Katharina S. Shaw, Ruth Ann Vleugels, Elena Massarotti, Karen H. Costenbader, Michael B. Brenner, James A. Lederer, Judd F. Hultquist, Jaehyuk Choi,Deepak A. Rao
4. ‘Saturation genome editing of BAP1 functionally classifies somatic and germline variants‘ published in Nature genetics./Source/
Authors: Andrew J. Waters, Timothy Brendler-Spaeth, Danielle Smith, Victoria Offord, Hong Kee Tan, Yajie Zhao, Sofia Obolenski, Maartje Nielsen, Remco van Doorn, Jo-Ellen Murphy, Prashant Gupta, Charlie F. Rowlands, Helen Hanson, Erwan Delage, Mark Thomas, Elizabeth J. Radford, Sebastian S. Gerety, Clare Turnbull, John R. B. Perry, Matthew E. Hurles, David J. Adams
5.’Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Lung Cancer‘
ctDNA-guided adaptive de-escalation TKI treatment strategy is feasible for patients with advanced NSCLC and undetectable ctDNA for achieving complete remission after local consolidative therapy./Source/
Authors:
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023